header advert
Results 1 - 4 of 4
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_23 | Pages 83 - 83
1 Dec 2016
McNally M Ferguson J Diefenbeck M Lau A Stubbs D Scarborough M Ramsden A Atkins B
Full Access

Aim

Eradication of infection in chronic osteomyelitis requires effective dead space management after debridement. Residual bacteria in biofilm may be resistant to normal levels of systemic antibiotic penetrating bone and will contribute to recurrence of osteomyelitis. This study evaluated a new antibiotic-loaded biocomposite in the eradication of chronic infection from bone defects.

Patients and Method

We report a prospective study of 100 patients with Cierny and Mader types III and IV chronic osteomyelitis, in 105 bones. Osteomyelitis followed open fracture or ORIF of closed fractures in 71%. Nine had concomitant septic arthritis. 80% had comorbidities (Cierny-Mader Class B hosts). Ten had infected non-unions.

All patients were treated by a multidisciplinary team with a single-stage protocol including; debridement, multiple sampling, culture-specific systemic antibiotics, stabilisation, dead space filling with Cerament G™ and immediate primary skin closure.

Stabilisation was required in 21 cases and 5 required joint fusion as part of the initial surgery. Plastic surgical skin closure was needed in 23 cases (18 free flaps).

Patients were followed up for a minimum of one year (mean 19.5 months; 12–34).


Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_20 | Pages 57 - 57
1 Nov 2016
Lanting B Tan S Lau A Teeter M Del Balso C McCalden R MacDonald S Vasarhelyi E McAuley J Naudie D Howard J
Full Access

Trunnionosis in modular hip arthroplasty has recently been recognised to be clinically important. Gaining an understanding of how the material interface at the head-trunnion affects the tribology at the modular junctions has current clinical implications as well as an implication on future implant selection and material choice. This matched-cohort study aims to compare tribocorrosion between ceramic and cobalt-chromium trunnions and to investigate other factors that contribute to the difference in tribocorrosion if present.

All hip prostheses retrieved between 1999 and 2015 at one centre were reviewed. Fifty two ceramic heads were retrieved, and these were matched to a cobalt-chromium cohort according to taper design, head size, neck length and implantation time in that order. The two cohorts were similar in male:female ratio (p=0.32) and body mass index (p=0.15) though the ceramic group was younger than the cobalt-chromium group (56.6 (+/−)13.5 years for ceramic group vs 66.3 (+/−14.4) years for cobalt-chromium group; p=0.001). There was no significant difference in the reasons for revision between the two groups (p=0.42). The femoral head trunnions were examined by two independent observers using a previously published 4-point scoring technique. The trunnions were divided into three zones: apex, middle and base. The observers were blinded to clinical and manufacturing data where possible.

Ceramic head trunnions demonstrated a lower median fretting and corrosion score at the base zone (p<0.001), middle zone (p<0.001) and in the combined score (p<0.001). In a subgroup analysis by head size, ceramic heads had a lower fretting and corrosion score at 28mm head diameter (p<0.001). Within the ceramic group, taper design had a significant effect on fretting and corrosion in the apex zone (p=0.04). Taper design also had a similar effect in the cobalt-chromium group in the apex zone (p=0.03). For the ceramic trunnions, the largest effect was contributed by the difference between the 11/13 taper and the 12/14 taper. For the cobalt-chromium trunnions, the largest effect was contributed by the difference between the 5 degree 38′ 37″ taper and type 1 taper.

Ceramic head trunnions showed a significantly lower fretting and corrosion score as compared to cobalt-chromium trunnions. Ceramic heads had a lower score than cobalt-chromium heads at 28mm head diameter. Taper design had an effect on fretting and corrosion within each cohort.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXIX | Pages 86 - 86
1 Jul 2012
da Assunçã;o R Pelletier M Lau A Marsh R Bruce WM Walsh W
Full Access

Introduction

The role of porosity in the longevity of polymethylmethacrylate (PMMA) bone cement mantles remains unclear, although porosity reduction is probably desirable. It is not known whether pore patterns, pore distribution or pore morphology contribute to failure, since it is difficult to assess these features with traditional techniques. We used a novel microtomographic technique to quantitatively and qualitatively assess porosity in PMMA cements of differing viscosities to establish whether pore distribution can be effectively assessed and to document any differences in porosity (in both quantity, distribution and morphology). Each cement was also examined with and without the addition of vacuum, since this is thought to reduce porosity.

Methods and materials

Four PMMA bone cements of different viscosities (three of the same brand and the fourth chosen due to its popularity) were prepared and moulded according to established protocols (ASTM F451-99a), with and without the addition of vacuum. 25 samples per group (200 total) were prepared and densities for each sample calculated using Archimedes' principle. Four samples per group (total 32) were randomly selected for further analysis. These samples underwent micro-computer tomography (micro-CT) at a magnification of 20× and slice thickness of 13.67μm and reconstructed images were analysed with in-house developed software to measure pore size and volume. Results were analysed and compared with the two-sample T-test assuming significance at P<0.05. Qualitative assessment of pore character and distribution was made using three dimensional (3D) reconstruction.


Orthopaedic Proceedings
Vol. 93-B, Issue SUPP_II | Pages 101 - 101
1 May 2011
Smitham P Oliver R Pelletier M Lau A Okamoto K Vizesi F Yu Y Walsh W
Full Access

Introduction: Monobutyrin (MB) has been shown to be a potent angiogenic factor for adipose tissue. It is one of the many compounds secreted from adipocytes adding to the knowledge that adipose tissue is not merely a storage unit but has an endocrine function. Adipocytes and osteoblasts share a common precursor. In osteoporosis the proportion of fat in bone increases. As both are present at a fracture site the addition of MB may enhance fracture healing by stimulating angiogenesis.

Method: 138 Sprague Dawley rodents were ovarect-omised at 12 weeks of age. After a further 24 weeks each animal underwent a right closed femoral fracture stabilized with a retrograde k-wire using a standard model (Walsh et al. 1997). Animals were randomised into control (empty or substrate only) or MB of varying concentrations (2.5μg, 7.5μg, 25μg, 75μg). A percutaneous injection of 0.2mls of each of the above was then injected into the fracture site. Animals were culled at 1, 3 and 6 week time points post surgery. The right and left femurs were dissected out and analyzed using radiographic, mechanical testing, micro computed tomography and histology endpoints. Statistical analysis was perfomed with SPSS for windows.

Results: All animals recovered well from the procedure and no adverse reactions were noted following the addition of MB. A progression to union was seen with time in all groups. Mechanical testing did not result in a statistical difference between groups, however the trend showed improved healing in the 7.5μg Monobutyrin group. Radiographic grading again showed no statistical difference however, interestingly micro CT data showed an increasing trend in both trabecular number and bone surface area to volume with increasing concentrations of MB.

The histology results implied a potential acceleration in the early stage of fracture healing in the high dose (75 μg) MB group. However progression to union following this initial early phase acceleration was delayed as callus volume increased rather than union according to micro CT and histological data.

Discussion: The ability to augment fracture healing has significant clinical implications considering the “greying of society”. This study investigated the possibility of improving fracture healing by incorporating the angiogenic factor, Monobutyrin in an estrogen deficient animal model. Although the results do not conclusively demonstrate an improvement in fracture healing, they do imply that MB does affect the early phase of fracture healing in the estrogen deficient model. This study is limited in that the effects of MB on fracture healing in a non-estrogen deficient model was not considered. The ideal release kinetics for Monobutyrin as well as other factors remains unknown.